KPCB XIV Founders Fund, LLC
CIK 1546197 · last filed 2019-08-06
KPCB XIV Founders Fund, LLC is a corporate insider who has filed 2 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing shows the insider sold $334.4M of BYND on Aug 6, 2019. Across all open-market trades the lifetime net is −$334.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.94M
2
2
-$334.42M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BYND | 10%+ Owner | 7,027,601 | $0.56 | $3.94M | -$334.42M | 1 | 2019-08-06 |
| ARMO BioSciences, Inc. (ARMO) Delisted | 10%+ Owner | 0 | — | — | $0 | 1 | 2018-06-22 |
Recent Filings
2 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-08-06 | BYND | Sell (S) | −2,171,586 | -$334.42M | EDGAR |
| 2018-06-22 | ARMO BioSciences, Inc. (ARMO) Delisted | U | −25,600,098 | -$1.28B | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.